title: Influence of antioxidant (L- ascorbic acid) on tolbutamide induced hypoglycaemia/antihyperglycaemia in normal and diabetic rats.
abstract: BACKGROUND: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycaemia. Increased oxidative stress and decreased antioxidant levels are the leading cause of diabetes and diabetic complications. So it is felt that supplementation of antioxidants may be useful in controlling the glucose levels and to postpone the occurrence of diabetic complications. The objective of our study is to find the influence of antioxidant supplementation (L-ascorbic acid) on tolbutamide activity in normal and diabetic rats. METHODS: L- ascorbic acid/tolbutamide/L-ascorbic acid + tolbutamide were administered orally to 3 different groups of albino rats of either sex in normal and diabetic condition. Blood samples were collected from retro-orbital puncture at different time intervals and were analyzed for blood glucose by GOD-POD method. Diabetes was induced by alloxan 100 mg/kg body weight administered by I.P route. RESULTS: L-ascorbic acid/ tolbutamide produced hypoglycaemic activity in a dose dependant manner in normal and diabetic condition. In the presence of L-ascorbic acid, tolbuatmide produced early onset of action and maintained for longer period compared to tolbutamide matching control. CONCLUSION: Supplementation of antioxidants like L-ascorbic acid was found to improve tolbutamide response in normal and diabetic rats.
authors.affiliation: Pharmacology Division, University College of Pharmaceutical sciences, Andhra University, Visakhapatnam, – 530 003, India. nandinisai@hotmail.com.
authors.forename: Satyanarayana
authors.initials: S
authors.lastname: Sreemantula
authors.forename: Eswar K
authors.initials: EK
authors.lastname: Kilari
authors.forename: Vishnu A
authors.initials: VA
authors.lastname: Vardhan
authors.forename: Rajasekhar
authors.initials: R
authors.lastname: Jaladi
references.citation: J Clin Endocrinol Metab. 1982 Jan;54(1):95-100
references.pmid: 7033271
references.citation: Clin Chim Acta. 1999 Jun 15;284(1):31-43
references.pmid: 10437641
references.citation: J Clin Endocrinol Metab. 1981 Dec;53(6):1256-62
references.pmid: 7028776
references.citation: J Clin Pathol. 1969 Mar;22(2):158-61
references.pmid: 5776547
references.citation: Pathol Int. 1999 Feb;49(2):91-102
references.pmid: 10355961
references.citation: Mutat Res. 2001 Feb 20;490(2):123-9
references.pmid: 11342238
references.citation: J Am Coll Nutr. 1996 Oct;15(5):458-61
references.pmid: 8892171
references.citation: Diabetologia. 1997 Jun;40(6):647-53
references.pmid: 9222643
references.citation: J Pharm Pharmacol. 1989 May;41(5):345-6
references.pmid: 2569525
references.citation: Front Biosci. 1999 Mar 15;4:D339-45
references.pmid: 10077544
references.citation: J Int Fed Clin Chem. 1998 Mar;10(1):21-3
references.pmid: 10181011
references.citation: Arzneimittelforschung. 1980;30(1):21-9
references.pmid: 6989374
references.citation: Diabetes. 1996 Apr;45(4):471-7
references.pmid: 8603769
references.citation: Lancet. 1984 Jun 23;1(8391):1396-7
references.pmid: 6145845